These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7598734)

  • 1. The proton pump inhibitor, E3810, binds to the N-terminal half of the alpha-subunit of gastric H+,K(+)-ATPase.
    Morii M; Hamatani K; Takeguchi N
    Biochem Pharmacol; 1995 Jun; 49(12):1729-34. PubMed ID: 7598734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different biochemical modes of action of two irreversible H+,K(+)-ATPase inhibitors, omeprazole and E3810.
    Morii M; Takeguchi N
    J Biol Chem; 1993 Oct; 268(29):21553-9. PubMed ID: 8408006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligomeric regulation of gastric H+,K+-ATPase.
    Morii M; Hayata Y; Mizoguchi K; Takeguchi N
    J Biol Chem; 1996 Feb; 271(8):4068-72. PubMed ID: 8626741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory action of E3810 on H+,K(+)-ATPase and gastric acid secretion in vitro].
    Fujisaki H; Oketani K; Shibata H; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Takeguchi N
    Nihon Yakurigaku Zasshi; 1993 Dec; 102(6):389-97. PubMed ID: 8282270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding site of omeprazole in hog gastric H+,K(+)-ATPase.
    Morii M; Takata H; Takeguchi N
    Biochem Biophys Res Commun; 1990 Mar; 167(2):754-60. PubMed ID: 2157414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potency of substituted benzimidazoles such as E3810, omeprazole, Ro 18-5364 to inhibit gastric H+, K(+)-ATPase is correlatedwith the rate of acid-activation of the inhibitor.
    Morii M; Takata H; Fujisaki H; Takeguchi N
    Biochem Pharmacol; 1990 Feb; 39(4):661-7. PubMed ID: 2154989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.
    Besancon M; Simon A; Sachs G; Shin JM
    J Biol Chem; 1997 Sep; 272(36):22438-46. PubMed ID: 9278394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of inhibition of H+, K(+)-ATPase by sodium 2-[[4-(3- methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole (E3810).
    Nochi S; Yokoyama Y; Narukawa M; Ebine K; Murahashi M; Kawakami Y; Asakawa N; Sato T
    Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):552-8. PubMed ID: 8882453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [H+, K+ -ATPase, H+ -ATPase].
    Takeguchi N; Asano S; Morii M
    Nihon Rinsho; 1996 Mar; 54(3):595-600. PubMed ID: 8904210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New fluorescent probes E3810 and methoxy E3810 for determining distributions of the apical membrane and the acidic compartment of gastric acid secreting cells.
    Takeguchi N; Yamanouchi T; Sakai H; Morii M
    Jpn J Physiol; 1992; 42(1):75-88. PubMed ID: 1320706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently.
    Tomiyama Y; Morii M; Takeguchi N
    Biochem Pharmacol; 1994 Nov; 48(11):2049-55. PubMed ID: 7802694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.
    Fujisaki H; Shibata H; Oketani K; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Yamaguchi M; Sakai H; Takeguchi N
    Biochem Pharmacol; 1991 Jul; 42(2):321-8. PubMed ID: 1650210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of a new H(+)-K+ ATPase inhibitor (E3810) and its four metabolites in human plasma by high-performance liquid chromatography.
    Nakai H; Shimamura Y; Kanazawa T; Yasuda S; Kayano M
    J Chromatogr B Biomed Appl; 1994 Oct; 660(1):211-20. PubMed ID: 7858718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The site of action of pantoprazole in the gastric H+/K(+)-ATPase.
    Shin JM; Besancon M; Simon A; Sachs G
    Biochim Biophys Acta; 1993 Jun; 1148(2):223-33. PubMed ID: 8389196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of gastric (H+ + K+)-ATPase by the substituted benzimidazole, picoprazole.
    Wallmark B; Sachs G; Mardh S; Fellenius E
    Biochim Biophys Acta; 1983 Feb; 728(1):31-8. PubMed ID: 6299338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo.
    Shin JM; Sachs G
    Biochem Pharmacol; 2004 Dec; 68(11):2117-27. PubMed ID: 15498502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori.
    Hirai M; Azuma T; Ito S; Kato T; Kohli Y
    J Gastroenterol; 1995 Aug; 30(4):461-4. PubMed ID: 7550855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revealing the Mechanistic Pathway of Acid Activation of Proton Pump Inhibitors To Inhibit the Gastric Proton Pump: A DFT Study.
    Jana K; Bandyopadhyay T; Ganguly B
    J Phys Chem B; 2016 Dec; 120(51):13031-13038. PubMed ID: 27992223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of acid secretion following treatment with proton pump inhibitors.
    Shin JM; Sachs G
    Gastroenterology; 2002 Nov; 123(5):1588-97. PubMed ID: 12404233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
    Shin JM; Homerin M; Domagala F; Ficheux H; Sachs G
    Biochem Pharmacol; 2006 Mar; 71(6):837-49. PubMed ID: 16405921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.